Literature DB >> 16322743

Immune evasion by staphylococci.

Timothy J Foster1.   

Abstract

Staphylococcus aureus can cause superficial skin infections and, occasionally, deep-seated infections that entail spread through the blood stream. The organism expresses several factors that compromise the effectiveness of neutrophils and macrophages, the first line of defence against infection. S. aureus secretes proteins that inhibit complement activation and neutrophil chemotaxis or that lyse neutrophils, neutralizes antimicrobial defensin peptides, and its cell surface is modified to reduce their effectiveness. The organism can survive in phagosomes, express polysaccharides and proteins that inhibit opsonization by antibody and complement, and its cell wall is resistant to lysozyme. Furthermore, S. aureus expresses several types of superantigen that corrupt the normal humoral immune response, resulting in anergy and immunosuppression. In contrast, Staphylococcus epidermidis must rely primarily on cell-surface polymers and the ability to form a biolfilm to survive in the host.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16322743     DOI: 10.1038/nrmicro1289

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  456 in total

1.  Fluorescent reporters for studies of cellular localization of proteins in Staphylococcus aureus.

Authors:  Pedro M Pereira; Helena Veiga; Ana M Jorge; Mariana G Pinho
Journal:  Appl Environ Microbiol       Date:  2010-05-07       Impact factor: 4.792

2.  ABI domain-containing proteins contribute to surface protein display and cell division in Staphylococcus aureus.

Authors:  Matthew B Frankel; Brandon M Wojcik; Andrea C DeDent; Dominique M Missiakas; Olaf Schneewind
Journal:  Mol Microbiol       Date:  2010-10       Impact factor: 3.501

3.  Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo.

Authors:  Francis Alonzo; Meredith A Benson; John Chen; Richard P Novick; Bo Shopsin; Victor J Torres
Journal:  Mol Microbiol       Date:  2011-12-20       Impact factor: 3.501

Review 4.  Exploring Staphylococcus aureus pathways to disease for vaccine development.

Authors:  Andrea DeDent; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Semin Immunopathol       Date:  2011-12-01       Impact factor: 9.623

5.  Convertase inhibitory properties of Staphylococcal extracellular complement-binding protein.

Authors:  Ilse Jongerius; Brandon L Garcia; Brian V Geisbrecht; Jos A G van Strijp; Suzan H M Rooijakkers
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

6.  Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1beta secretion.

Authors:  Takahiro Shimada; Bong Goo Park; Andrea J Wolf; Constantinos Brikos; Helen S Goodridge; Courtney A Becker; Christopher N Reyes; Edward A Miao; Alan Aderem; Friedrich Götz; George Y Liu; David M Underhill
Journal:  Cell Host Microbe       Date:  2010-01-21       Impact factor: 21.023

7.  Staphylococcus aureus virulence attenuation and immune clearance mediated by a phage lysin-derived protein.

Authors:  Hang Yang; Jingjing Xu; Wuyou Li; Shujuan Wang; Junhua Li; Junping Yu; Yuhong Li; Hongping Wei
Journal:  EMBO J       Date:  2018-07-23       Impact factor: 11.598

8.  Identifying functional anti-Staphylococcus aureus antibodies by sequencing antibody repertoires of patient plasmablasts.

Authors:  Daniel R Lu; Yann-Chong Tan; Sarah Kongpachith; Xiaoyong Cai; Emily A Stein; Tamsin M Lindstrom; Jeremy Sokolove; William H Robinson
Journal:  Clin Immunol       Date:  2014-03-01       Impact factor: 3.969

9.  Keratinocytes produce IL-6 in response to desmoglein 1 cleavage by Staphylococcus aureus exfoliative toxin A.

Authors:  Cleo E Rolle; Juan Chen; Irena Pastar; Tatiana C P Cardenas; Roberto Perez; Suzanne Hower; Franco Ferracci; Richard Snyder; Marjana Tomic-Canic; Lisa R W Plano
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 10.  Nanoparticle-Based Therapies for Wound Biofilm Infection: Opportunities and Challenges.

Authors:  Min-Ho Kim
Journal:  IEEE Trans Nanobioscience       Date:  2016-03-02       Impact factor: 2.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.